Back to mobile site

More on QTTB

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+46.7% Growth)
- Ratings (6.4 Score)

Upcoming Events

- Earnings (11/5/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Q32 Bio (NQ:QTTB)
Delayed: 10.42 -0.12 (1.14%)
Prev. Close $10.54  
Open$10.57 
52 Wk High$ 
52 Wk Low$ 
Day High$10.75 
Day Low$10.30 
P/E N/A  
EPS$ 
Volume112,796 

Friends, Peers and Foes (?): AKBA, 0A3M, A1SN34, ABBV, ASND (more...)

Sep 21, 2026 09:16 AM Q32 Bio to present bempikibart trial data at EADV congress
Sep 21, 2026 09:15 AM Q32 Bio Announces Upcoming Late-Breaking Presentation of Results from Part B of the SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata at the European Academy of Dermatology and Venereology Co
Sep 16, 2026 07:34 AM Q32 Bio (QTTB) Reiterated at Overweight by Cantor Fitzgerald
Sep 14, 2026 07:16 AM Form 8-K Q32 Bio Inc. For: Sep 14
Sep 14, 2026 06:59 AM Q32 Bio names new chief medical and chief development officers
Sep 14, 2026 06:59 AM Q32 Bio Appoints José Trevejo, M.D., Ph.D., as Chief Medical Officer and Ellie Hershberger, Pharm.D., as Chief Development Officer
Aug 27, 2026 04:10 PM Form 4 Q32 Bio Inc. For: Aug 25 Filed by: Violette Shelia M.
Aug 27, 2026 04:10 PM Form 4 Q32 Bio Inc. For: Aug 25 Filed by: Morrison Jodie Pope
Aug 27, 2026 04:10 PM Form 4 Q32 Bio Inc. For: Aug 25 Filed by: Kalowski Lee
Aug 24, 2026 04:47 AM Morgan Stanley Starts Q32 Bio Inc. (QTTB) at Overweight
View All Articles

Entities mentioned with QTTB

View All Entities